Ranitidine Market Size Was Valued at USD 980 Million in 2023, and is Projected to Reach USD 1,370.89 Million by 2032, Growing at a CAGR of 3.8% From 2024-2032.

The rapid infuser market refers to the global community comprised of companies that design, produce and sell devices used to infuse the fluids, for instance blood, saline or medication, into the circulatory system of the patient in a critical or emergency context. Importance of these devices is felt most in areas where patients are likely to have compromised circulatory status and may need fluids replacement urgently, especially in the traumatology, surgery, and ICU. The rapid infusers are meant for high speeds and large volumes of fluids and are used to increase blood volume, stabilize the vital signs and avoiding shock, dehydration or hypothermia. Some of them include; flow rate management which is accurate; continuous monitoring; and in some models, the possibility to warm the fluids before infusion to counter the consequences of cold blood or saline. Key drivers for growth include growing cases of trauma and surgical operations, rising diseases related to the state of health, and improvements of clinical technology in the administration of the fluids. There is increased worrying of emergency care services especially in the rural and urban setting, as well as the aging population that needs intensive emergency medical care, and therefore the market for the rapid infuser will grow considerably.

Rare Disease Drugs Market Size Was Valued at USD 185.39 Billion in 2023, and is Projected to Reach USD 479.65 Billion by 2032, Growing at a CAGR of 11.8 % From 2024-2032.